G. Bruixola

Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer

N. Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella et al. · Annals of Oncology · 2019 · 283 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer

G. Bruixola, Javier Caballero‐Villarraso, Federica Papaccio et al. · ESMO Open · 2018 · 72 citations · Full text

Medicine, Oncology, Chemotherapy +15

Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study

Valentina Gambardella, Pasquale Lombardi, Juan Antonio Carbonell‐Asins et al. · British Journal of Cancer · 2021 · 33 citations · Full text

Medicine, Molecular Medicine, Oncology +16

An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib

Robert Díaz Beveridge, G. Bruixola, David Lorente et al. · Clinical & Translational Oncology · 2017 · 20 citations

Medicine, Oncology, Pharmacotherapy +14

Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype

N. Tarazona Llavero, Francisco Gimeno-Valiente, Valentina Gambardella et al. · Annals of Oncology · 2019 · 12 citations

Medicine, Molecular Genetics, Oncology +17